PubRank

M Onji

Author PubWeight™ 78.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990 6.96
2 Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J Hepatol 2001 1.67
3 Interferon therapy for patients more than 60 years of age with chronic hepatitis C. J Gastroenterol Hepatol 1995 1.48
4 Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes. Biochem Biophys Res Commun 1998 1.31
5 Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001 1.28
6 Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. J Hepatol 1999 1.27
7 Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011 1.26
8 Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology 1996 1.21
9 Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 1999 1.16
10 Noninvasive diagnosis of the degree of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis C virus. Eur J Clin Invest 2001 1.15
11 Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells. Immunology 1993 1.13
12 Hepatitis B virus (HBV)-transgenic mice as an investigative tool to study immunopathology during HBV infection. Int J Exp Pathol 1998 1.07
13 Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon-gamma: abrogation of immune response defect to a T-cell-dependent antigen. Immunology 1996 1.07
14 Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin Exp Immunol 2004 1.06
15 Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol 2002 1.05
16 Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1999 1.03
17 Production of antibody to hepatitis B surface antigen (anti-HBs) by murine hepatitis B virus carriers: neonatal tolerance versus antigen presentation by dendritic cells. Immunology 1997 1.01
18 Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis. Cancer Lett 2001 1.01
19 Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 2000 0.99
20 Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues. Clin Biochem 2001 0.98
21 Prognostic importance of antigen-presenting dendritic cells during vaccine therapy in a murine hepatitis B virus carrier. Immunology 1999 0.97
22 Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2001 0.97
23 Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases. Hepatogastroenterology 1988 0.96
24 Hepatitis C virus clearance is prominent in women in an endemic area. J Gastroenterol Hepatol 2000 0.96
25 Amyloidosis localized in the sigmoid colon. J Gastroenterol 1996 0.95
26 Mechanism and therapeutic potential of DNA-based immunization against the envelope proteins of hepatitis B virus in normal and transgenic mice. Immunology 2001 0.95
27 Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis. Cancer Lett 2000 0.95
28 Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses. Clin Exp Immunol 2005 0.93
29 Existence of TT virus DNA in extracellular body fluids from normal healthy Japanese subjects. Intervirology 2000 0.93
30 Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy. Clin Exp Immunol 2004 0.92
31 Dendritic cells and chronic hepatitis virus carriers. Intervirology 2001 0.92
32 Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 1997 0.91
33 Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995 0.89
34 Increased nitric oxide (NO) production by antigen-presenting dendritic cells is responsible for low allogeneic mixed leucocyte reaction (MLR) in primary biliary cirrhosis (PBC). Clin Exp Immunol 1998 0.89
35 Abnormal gastric motility in liver cirrhosis: roles of secretin. Dig Dis Sci 1998 0.89
36 A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid. Clin Exp Immunol 2004 0.88
37 The CD81 expression in liver in hepatocellular carcinoma. Int J Mol Med 2001 0.88
38 Localization and characterization of antigen-presenting dendritic cells in the gastric mucosa of murine and human autoimmune gastritis. Eur J Clin Invest 2000 0.86
39 Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur J Clin Invest 2001 0.85
40 Mechanisms of alcoholic liver disease: cytokines. Alcohol Clin Exp Res 2001 0.85
41 Potent synergistic effect of sho-saiko-to, a herbal medicine, during vaccine therapy in a murine model of hepatitis B virus carrier. Eur J Clin Invest 1999 0.85
42 Immunohistochemical localization of antigen presenting cells in liver from patients with primary biliary cirrhosis; highly restricted distribution of CD83-positive activated dendritic cells. Pathol Res Pract 1999 0.84
43 Antigen-presenting cells at the liver tissue in patients with chronic viral liver diseases: CD83-positive mature dendritic cells at the vicinity of focal and confluent necrosis. Hepatol Res 2001 0.84
44 Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell. Clin Exp Immunol 2008 0.84
45 Cronkhite-Canada syndrome. A case report and analytical review of 23 other cases reported in Japan. Gastroenterol Jpn 1979 0.84
46 Morphometric analysis of lymphatic and blood vessels in human chronic viral liver diseases. Am J Pathol 1998 0.84
47 Increased levels of serum interleukin-12 in Graves' disease. Eur J Endocrinol 1999 0.84
48 Safety and immunogenicity of hepatitis B surface antigen-pulsed dendritic cells in patients with chronic hepatitis B. J Viral Hepat 2011 0.84
49 Serum IL-8 levels and localization of IL-8 in liver from patients with chronic viral hepatitis. Hepatogastroenterology 1999 0.83
50 Primary carcinoid tumor of the liver: report of two cases with an emphasis on US findings. Abdom Imaging 2002 0.83
51 In situ characterization of dendritic cells occurring in the islets of nonobese diabetic mice during the development of insulitis. Pancreas 2000 0.83
52 Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C. Gastroenterol Jpn 1993 0.81
53 Unique features of dendritic cells in IFN-gamma transgenic mice: relevance to cancer development and therapeutic implications. Biochem Biophys Res Commun 1999 0.80
54 Assay of serum interleukin 8 levels in patients with alcoholic hepatitis. Alcohol Alcohol Suppl 1993 0.80
55 Induction of CINC (interleukin-8) production in rat liver by non-parenchymal cells. J Gastroenterol Hepatol 1998 0.79
56 Hepatitis C virus plus- and minus- strand RNA in hepatocellular carcinoma and adjoining nontumorous liver. J Med Virol 1993 0.79
57 Chemoembolization and percutaneous ethanol injection for intrahepatic recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 1997 0.79
58 p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Mol Carcinog 1995 0.79
59 The effectiveness of interferon therapy on occurrence of hepatocellular carcinoma in chronic hepatitis C. Oncol Rep 1998 0.79
60 Subclass restriction of immunoglobulin G in liver cirrhosis. J Gastroenterol Hepatol 1991 0.78
61 Dendritic cells produce interleukin-12 in hyperthyroid mice. Eur J Endocrinol 1999 0.78
62 Increased levels of serum interleukin-18 in Graves' disease. Thyroid 2000 0.78
63 Immunologic effects on peripheral lymphoid cells from patients with chronic hepatitis type B during administration of recombinant interleukin 2. Clin Exp Immunol 1988 0.78
64 Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy. J Gastroenterol Hepatol 2000 0.78
65 Serum paraoxonase activity and genotype distribution in Japanese patients with diabetes mellitus. Intern Med 1998 0.78
66 [A case of hemophagocytic syndrome with severe liver injury manifestating adult Still's disease]. Nihon Rinsho Meneki Gakkai Kaishi 1997 0.78
67 Hepatitis B virus replication in dark reddish patchy markings appearing on the hepatic surface. Gastrointest Endosc 1990 0.78
68 Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver 1993 0.77
69 Anti-HCV immunoglobulin M antibody in patients with hepatitis C. J Gastroenterol Hepatol 1992 0.77
70 The seroepidemiology of hepatitis A and B in a Japanese town. Asia Pac J Public Health 1993 0.77
71 Mechanism of restoration of immune responses of patients with chronic hepatitis B during lamivudine therapy: increased antigen processing and presentation by dendritic cells. J Viral Hepat 2011 0.77
72 In situ detection of mutated hepatitis B virus in microdissected, formalin-fixed liver tissues from patients with chronic hepatitis B. J Hepatol 1999 0.77
73 Response to interferon in chronic hepatitis C due to mixed genotype infection. J Gastroenterol Hepatol 1996 0.77
74 Enhancement of retrovirus-mediated gene transfer to rat liver in vivo by infusion of hepatocyte growth factor and triiodothyronine. J Hepatol 2000 0.76
75 Spontaneous occurrence of autoimmune cholangitis in senescent mice. J Gastroenterol Hepatol 1993 0.76
76 Changes in gastrointestinal lymph and blood vessels in patients with cirrhotic portal hypertension. J Gastroenterol 2001 0.76
77 Detection of hepatitis B surface antigen in lymphoid follicle in patients with chronic hepatitis type B. Gastroenterol Jpn 1989 0.76
78 HBV-DNA hybridization in hepatocellular carcinoma associated with alcohol in Japan. J Med Virol 1989 0.76
79 Glucagon attenuates the action of insulin on glucose output in the liver of the Goto-Kakizaki rat perfused in situ. Pflugers Arch 2001 0.76
80 Prediction of interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C. J Gastroenterol Hepatol 1996 0.76
81 Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats. Eur J Pharmacol 2000 0.75
82 Apoptosis of rat gastric mucosa and of primary cultures of gastric epithelial cells by indomethacin: role of inducible nitric oxide synthase and interleukin-8. Int J Exp Pathol 2001 0.75
83 In what types of diseases does anti-carbonic anhydrase II antibody-positivity have clinical significance? J Gastroenterol 1999 0.75
84 Dendritic cell-based immunotherapy for hepatocellular carcinoma. J Gastroenterol 2001 0.75
85 Triiodothyronine enhances expression of the interleukin-2 receptor alpha chain. Endocr J 1999 0.75
86 Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Med 1992 0.75
87 Leucocyte adherence inhibition assay for immunodiagnosis of hepatocellular carcinoma. Gastroenterol Jpn 1984 0.75
88 Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C. J Gastroenterol 1994 0.75
89 Intrafamilial transmission of hepatitis C virus in Japan. Gastroenterol Jpn 1991 0.75
90 [Leucocyte adherence inhibition with cryopresfrved mononuclear cells and autologous tumor extract (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1980 0.75
91 Serum alpha-fetoprotein-positive gastric carcinoid with liver metastasis. Virchows Arch A Pathol Anat Histol 1980 0.75
92 GB virus C/hepatitis G virus infection in autoimmune liver diseases. J Gastroenterol 1998 0.75
93 Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer. Gastroenterol Jpn 1984 0.75
94 Mutation of the core region of HBV-DNA and submassive hepatic necrosis in patients with anti-HBe-positive chronic hepatitis B. J Gastroenterol Hepatol 1992 0.75
95 [Blood level of 5-fluorouracil (5-FU) by oral administration of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and tegafur in patients with hepatocellular carcinoma]. Nihon Gan Chiryo Gakkai Shi 1985 0.75
96 [Primary biliary cirrhosis: a study on developmental pathology and physiopathology]. Nihon Naika Gakkai Zasshi 1999 0.75
97 An autopsy case of primary biliary cirrhosis with severe interstitial pneumonia. Intern Med 2001 0.75
98 [A comparative study on the histochemical visualization of hepatitis-B surface antigen in liver biopsy material (author's transl)]. Rinsho Byori 1982 0.75
99 Immunoglobulin G subclasses of antibodies to hepatitis B core antigen in HBs antigen positive liver diseases. J Gastroenterol Hepatol 1991 0.75
100 [Etiological implication of delta agent to HBsAg-positive liver diseases]. Rinsho Byori 1987 0.75
101 Recurrence of gastric ulcer dependent upon strain differences of Helicobacter pylori in urease B gene. Dig Dis Sci 2000 0.75
102 Hyperplastic liver nodules associated with early-stage primary biliary cirrhosis mimicking hepatocellular carcinoma. Dig Dis Sci 2000 0.75
103 Prevalence of hepatitis C virus antibody in an area endemic for hepatitis B virus and human T cell leukaemia virus. J Gastroenterol Hepatol 1992 0.75
104 [A case of Cronkhite-Canada syndrome presenting accentuated fibrinolytic activity of gastrointestinal mucosa (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1981 0.75
105 Decreased interleukin-2 receptor beta chain expression by peripheral blood lymphocytes in chronic liver disease. J Gastroenterol Hepatol 1992 0.75
106 Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene. J Gastroenterol Hepatol 1999 0.75
107 [Diagnostic value of anti-HBc IgM detection by an enzyme-immunoassay method in various liver diseases (type B)]. Rinsho Byori 1985 0.75
108 [Detection of Ki-67 in liver biopsy specimens using monoclonal antibody to Mib-1]. Rinsho Byori 1999 0.75
109 Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance. Gastroenterol Jpn 1992 0.75
110 [R-PHA and PHA methods for the detection of HBeAg and anti-HBe]. Rinsho Byori 1984 0.75
111 [A cell kinetic study of liver cells in various liver diseases by the detection of DNA polymerase alpha]. Nihon Shokakibyo Gakkai Zasshi 1989 0.75
112 Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C. Hepatogastroenterology 1992 0.75
113 An unusual case of subclinical diffuse glucagonoma coexisting with two nodules in the pancreas: characteristic features on computed tomography. Clin Res Hepatol Gastroenterol 2012 0.75
114 [Sequential changes in blood concentrations of tegafur and 5-FU during oral administration of fine granules of tegafur in patients with primary liver cancer]. Gan To Kagaku Ryoho 1982 0.75
115 Laparoscopic histopathological analysis of "gentle undulation" findings observed in patients with primary biliary cirrhosis. Endoscopy 1987 0.75
116 [Approach to diagnosis of drug-induced liver diseases]. Nihon Naika Gakkai Zasshi 1995 0.75
117 [Detection of minus strand HCV RNA in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR)]. Rinsho Byori 1993 0.75
118 [Drug-induced hepatic dysfunction and jaundice]. Nihon Naika Gakkai Zasshi 1997 0.75
119 Three patients with autoimmune cholangiopathy treated with prednisolone. J Gastroenterol 1998 0.75
120 [Tissue polypeptide antigen (TPA) in liver tissue from patients with hepatocellular carcinoma]. Nihon Shokakibyo Gakkai Zasshi 1987 0.75
121 [Virological studies on patients with anti-HBe positive chronic hepatitis showing GPT fluctuation]. Nihon Shokakibyo Gakkai Zasshi 1987 0.75
122 Immunohistochemical localization of metallothionein in hepatocellular carcinoma: preferential expression in non-cancerous cirrhotic nodules. Oncol Rep 1998 0.75
123 [Serological diagnosis of viral hepatitis type A and B]. Rinsho Byori 1982 0.75
124 Non-invasive approach for diagnosing atrophic gastritis using the 13C-bicarbonate breath test. Int J Mol Med 2001 0.75
125 [The analysis of background factors in HBs Ag positive liver cirrhosis--relationship with alcohol]. Nihon Rinsho 1995 0.75
126 Tc-99m PMT hepatobiliary scintigraphy in the differential diagnosis of extrahepatic metastases and hepatocellular carcinoma. Clin Nucl Med 2000 0.75
127 Human herpesvirus 7 infection of CD4+(+) T cells does not require expression of the OKT4 epitope. J Gen Virol 1996 0.75
128 [Analysis of the mechanisms relating the localization of HCV core protein and hepatic injury--an immunohistochemical study]. Nihon Rinsho 1995 0.75
129 Change of hepatitis B virus DNA distribution associated with the progression of chronic hepatitis. Liver 1988 0.75
130 Hepatic triglyceride lipase and lipoprotein lipase activities in post-heparin plasma of patients with various cancers. Jpn J Cancer Res 1985 0.75
131 [Prognostic diagnosis and follow-up of acute viral hepatitis]. Nihon Naika Gakkai Zasshi 1990 0.75
132 [A staining method of PIVKA-II by an indirect immunoenzyme technic]. Rinsho Byori 1989 0.75
133 [The detection of anti-HBc by a passive hemagglutination method]. Rinsho Byori 1985 0.75
134 [Changes in the electroencephalogram, cerebral visual evoked potential and plasma NH3 levels in adult type citrullinemia]. Rinsho Byori 1986 0.75
135 Presence of a translational stop codon in the precore region of HBVDNA in the HBeAg positive stage of chronic hepatitis B. Gastroenterol Jpn 1990 0.75
136 [T cell subsets identified by monoclonal antibodies in liver diseases]. Nihon Shokakibyo Gakkai Zasshi 1982 0.75
137 A case report of drug-induced allergic hepatitis probably due to the N-methyltetrazolethiol group cephalosporin. Arerugi 1994 0.75
138 [Beta 2-microglobulin of peripheral blood mononuclear cells measured by enzyme immunoassay using microplate]. Rinsho Byori 1989 0.75
139 Retreatment with interferon in chronic hepatitis C. J Hepatol 1994 0.75